经月经检测市场规模、份额及成长分析（依产品类型、治疗方法、最终用户及地区划分）－2026-2033年产业预测

全球月经疼痛测试市场规模预计在 2024 年达到 38.9 亿美元，从 2025 年的 42.1 亿美元增长到 2033 年的 78.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.1%。

全球月经检测市场正经历显着成长，这主要得益于月经盛行率的上升、人们对月经健康意识的增强以及诊断技术的进步。随着月经患者人数的增加，对临床评估和检测服务的需求也随之激增。政府推出的支持性政策，例如资助月经健康研究和推广全国筛检措施，进一步提高了月经检测的可及性。生殖健康诊所的增加以及人们对不孕症治疗日益增长的兴趣，也拓展了检测机会。人工智慧、机器学习和物联网等创新技术透过对症状和模式进行数据分析，正在变革诊断方式；而扩增实境（AR）和虚拟实境（VR）技术则在提升临床医生的培训水准。科技与意识的融合正在塑造月经检测的未来。

全球月经检测市场驱动因素

随着原发性和续发性月经的盛行率不断上升，越来越多的女性主动寻求医疗协助以应对慢性或严重的月经，这推动了对明确诊断方案的需求。这种日益增强的意识进一步强化了月经检测的必要性。此外，致力于促进女性健康的政府和非政府组织的活动也进一步提升了月经紊乱疾病筛检的重要性。因此，健康意识的提高和教育活动的开展所产生的协同效应正在推动全球月经检测市场的扩张。

限制全球月经检测市场的因素

全球月经检测市场面临许多挑战，这些挑战源自于将月经视为耻辱的文化观念。这种污名不仅阻碍了公开讨论，也限制了女性获得必要的月经健康服务。在较保守的社区，女性往往面临许多障碍，难以将自身健康放在第一位，尤其是在疼痛症状常被轻描淡写的情况下。此外，即使患者愿意分享自身经历，根深蒂固的性别偏见也可能阻碍医疗服务提供者进行更深入的调查，从而影响月经的诊断和治疗。这些以及其他社会因素都对市场发展构成限制。

全球月经检测市场趋势

全球月经检测市场正呈现显着成长趋势，这主要得益于人们对月经健康的认识不断提高，以及相关讨论日趋规范化。政府和非营利组织主导的教育活动有效打破了与月经疼痛相关的污名，鼓励更多女性寻求月经检测及相关医疗服务。这种日益增长的认知推动了对先进检测解决方案的需求，例如荷尔蒙水平检测、超音波和创新的深度学习成像技术，这些解决方案能够提供个人化的评估。随着女性寻求更全面的治疗方案，市场呈现成长态势，这也反映了更广泛的健康趋势，即女性生殖健康和福祉日益受到重视。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 顾客购买行为分析

全球月经检测市场规模（依产品类型及复合年增长率划分）（2026-2033 年）

• 原发性经痛检查
• 次发性月经

全球月经检测市场规模（依治疗方法和复合年增长率划分）（2026-2033 年）

• 止痛药
• 荷尔蒙疗法
• 外科手术

全球月经检测市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院和诊所
• 研究中心

全球月经检测市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Pfizer Inc.
• Bayer AG
• Johnson & Johnson Services, Inc.
• Quin
• Abbott Laboratories
• Merck & Co., Inc.
• Global Pharma plc
• Mylan NV
• Teva Pharmaceutical Industries Ltd.
• Proteomics Inc.
• Boehringer Ingelheim International GmbH
• Ferring Pharmaceuticals

结论与建议

Global Dysmenorrhea Testing Market size was valued at USD 3.89 Billion in 2024 and is poised to grow from USD 4.21 Billion in 2025 to USD 7.84 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global dysmenorrhea testing market is experiencing significant growth driven by the increasing prevalence of dysmenorrhea, heightened awareness surrounding menstrual health, and advancements in diagnostic technologies. As more individuals face menstrual pain, there is a surge in demand for clinical evaluations and testing services. Supportive government policies promoting funding for menstrual health research and national screening initiatives have further improved access to dysmenorrhea testing. The rise of reproductive health clinics and awareness around fertility has amplified testing opportunities. Innovations such as artificial intelligence, machine learning, and IoT are transforming diagnostics by enabling data analysis of symptoms and patterns, while augmented and virtual reality are enhancing clinician training. This convergence of technology and awareness is shaping the future landscape of dysmenorrhea testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dysmenorrhea Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dysmenorrhea Testing Market Segments Analysis

Global Dysmenorrhea Testing Market is segmented by Product Type, Type of Treatment, End User and region. Based on Product Type, the market is segmented into Primary Dysmenorrhea Testing and Secondary Dysmenorrhea Testing. Based on Type of Treatment, the market is segmented into Pain Relievers, Hormonal Therapy and Surgery. Based on End User, the market is segmented into Hospitals and Clinics and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dysmenorrhea Testing Market

The rising prevalence of both primary and secondary dysmenorrhea has led to an increased demand for clear diagnostic solutions, as more women actively seek medical assistance for chronic or intense menstrual pain. This growing awareness has heightened the necessity for dysmenorrhea testing. Additionally, the efforts of governments and non-governmental organizations promoting women's health have further stimulated the importance of medical screenings for menstrual disorders. As a result, the combination of heightened health awareness and advocacy initiatives is driving the expansion of the Global Dysmenorrhea Testing market.

Restraints in the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market faces significant challenges rooted in cultural perceptions surrounding menstruation, which often view it as a source of shame. This stigma not only hampers open discussion but also restricts access to essential menstrual health services. In more conservative communities, women frequently encounter barriers that prevent them from prioritizing their health, particularly when experiencing painful symptoms that are commonly dismissed. Furthermore, even when patients communicate their experiences, healthcare providers may neglect to pursue further investigation due to inherent gender biases, ultimately impacting diagnosis and treatment for dysmenorrhea. Such societal factors contribute to the overall restraints in the market.

Market Trends of the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market is experiencing a significant upward trend driven by increasing awareness and the normalization of menstrual health discussions. Educational initiatives spearheaded by governments and nonprofit organizations are effectively breaking stigmas associated with menstrual pain, prompting more women to pursue dysmenorrhea testing and related healthcare services. This heightened awareness is fueling demand for advanced testing solutions, including hormonal profiling, ultrasounds, and innovative deep learning imaging techniques, which allow for personalized assessments. As women seek informed care options, the market is poised for growth, reflecting broader health trends focused on women's reproductive health and well-being.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Dysmenorrhea Testing Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Primary Dysmenorrhea Testing
• Secondary Dysmenorrhea Testing

Global Dysmenorrhea Testing Market Size by Type of Treatment & CAGR (2026-2033)

• Market Overview
• Market Overview
• Pain Relievers
• Hormonal Therapy
• Surgery

Global Dysmenorrhea Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Research Centers

Global Dysmenorrhea Testing Market Size & CAGR (2026-2033)

• North America (Product Type, Type of Treatment, End User)
  • US
  • Canada
• Europe (Product Type, Type of Treatment, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type of Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type of Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type of Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Pharma plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteomics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations